← FDA Drug Approvals (Drugs@FDA)

CEDILANID-D

NDA · New Drug Application · Sponsor: NOVARTIS

Drug application

FDA Application #
NDA009282
Application type
New Drug Application
Brand name
CEDILANID-D
Generic name
Deslanoside
Active ingredients
DESLANOSIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
NOVARTIS

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown